Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • MeixiaZhao
    Junior Member
    • Apr 2012
    • 9

    #1

    cufflinks 2.0.0

    I have just used the latest cufflinks 2.0.0 to run my previous data, as I want to detect if large differences occur. And I did find some very confuse results. For the significant differential expressed isoforms, the number of cufflinks 1.3.0 is 11380, but the number from cufflinks 2.0.0 reduced to 2371. And for the significant differential expressed genes is the same situation, 2692 vs 1353, respectively. Many genes or transcripts showed significant change in previous version, but now changed from "yes" to "no". As my data has no replicates, first I thought this may due to the option --min-reps-for-js-test, but even I changed the default 3 to 1, the results is same. I don't know if for publication, the results from which version I can use due to the large difference? Did anyone meet this kind of situation?
    Thanks!
  • sdriscoll
    I like code
    • Sep 2009
    • 436

    #2
    by design, cufflinks 2.0 will produce more conservative gene lists than previous versions. I think previous versions had a very high false discovery rate. i've only used cuffdiff from cufflinks 2.0 on two different sets of data but so far I'd say it's maybe overly strict..but the results make more sense than they did in v1.3.

    keep in mind that p-values on a N=1 comparison are kind of like magic. there's obviously very little statistical power there and DE tools should probably be overly conservative in that case. your data must have quite a bit of differential expression to produce a list that long with no replicates.

    the --min-reps-for-js-test option only applies to the splicing.diff, cds.diff and promoters.diff files. they found that with less than 3 replicates the false discovery rate in those files was excessively high.
    /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
    Salk Institute for Biological Studies, La Jolla, CA, USA */

    Comment

    • MeixiaZhao
      Junior Member
      • Apr 2012
      • 9

      #3
      Yeah, I understand. I'm just in a dilemma as the data showed so large differences.

      Comment

      • sdriscoll
        I like code
        • Sep 2009
        • 436

        #4
        If you've made decisions already based on the old results just stick to those. I think the new list is probably safer and for sure if the first list contained false positives they have been dropped from the new list. If it's not too much trouble for you I'd use the new list...unless of course it removed some genes of interest! That brings up another point though...right? Those p-values don't tell us the biological significance.
        /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
        Salk Institute for Biological Studies, La Jolla, CA, USA */

        Comment

        • luigra
          Junior Member
          • Jan 2012
          • 7

          #5
          Hi all,

          I tested cufflinks 2.0.0 and I quickly found that it has some problems (certainly more than the previous version): whit the same Data Set In the version 1.3.0 I obtained in the isoform_exp.diff file roughly the 40% of FAIL TEST. In the current version there are no FAIL but the number of NOTEST increased enormously (roughly to 90%) with the consequent reduction of significant DE isoforms. I would not believe to the results of cuffdiff 2.0.0
          Luigi Grassi
          Università degli Studi di Roma La Sapienza
          Dipartimento di Fisica
          Piazzale Aldo Moro 5, 00185 Roma

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            How Immunogenomics Decodes Immunity’s Genetic Blueprint
            by SEQadmin2




            The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

            This convergence of genetics, immunology, and computation...
            Today, 05:41 AM
          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-24-2026, 10:32 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-20-2026, 11:17 AM
          0 responses
          44 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-18-2026, 10:05 AM
          0 responses
          49 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-13-2026, 12:22 PM
          0 responses
          49 views
          0 reactions
          Last Post SEQadmin2  
          Working...